AMRX
USDAmneal Pharmaceuticals Inc. Class A Common Stock
实时价格
价格图表
关键指标
市场指标
开盘价
$11.010
最高价
$11.400
最低价
$10.940
成交量
3.47M
公司基本面
市值
3.6B
所属行业
Drug Manufacturers - Specialty & Generic
国家/地区
United States
交易统计
平均成交量
1.66M
交易所
NMS
货币
USD
52周价格范围
相关新闻
Piper Sandler Reiterates Overweight on Amneal Pharmaceuticals, Raises Price Target to $13
Piper Sandler analyst David Amsellem reiterates Amneal Pharmaceuticals with a Overweight and raises the price target from $11 to $13.
Amneal Reports Third Quarter 2025 Financial Results
‒ Q3 2025 Net Revenue of $785 million; GAAP Net Income of $2 million; Diluted Income per Share of $0.01 ‒‒ Adjusted EBITDA of $160 million; Adjusted Diluted EPS of $0.17 ‒‒ Updated 2025 Full Year Guidance ‒ BRIDGEWATER,
Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved the Company's
相关股票
HBANL
Huntington Bancshares Incorporated Depositary Shares Each Representing a 1/40th Interest in a Share of 6.875% Series J Non-Cumulative Perpetual Preferred Stock
REFR
Research Frontiers Incorporated
RCAT
Red Cat Holdings Inc.
GOLF
Acushnet Holdings Corp.
INBK
First Internet Bancorp
保持更新
设置价格提醒，获取AI分析更新和实时市场新闻。